Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 4
1(25.0%)
Phase 1
1(25.0%)
4Total
N/A(2)
Phase 4(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06054516Recruiting

Hyperpolarized MRSI in Ischemic Heart Disease: A Metabolic Investigation of the Heart Muscle

Role: lead

NCT03514108Phase 4Completed

DANHEART (H-HeFT and Met-HeFT)

Role: lead

NCT06121323Not ApplicableCompleted

Physiological Effects of Lactate in Individuals With Chronic Heart Failure

Role: lead

NCT04613193Not ApplicableRecruiting

Blood Pressure Reduction in Patients With Asymptomatic Aortic VALVE Stenosis

Role: lead

NCT03122769Phase 1Completed

Cardiac Uptake of Metformin, Visualized by Positron Emission Tomography

Role: lead

All 5 trials loaded